This new generic medicine is designed to be a simple, once-daily treatment for children as young as three months old who ...
The fixed-dose combination of Abacavir 60 mg/Dolutegravir 5 mg/Lamivudine 30 mg tablets for oral suspension is a once-daily ...
GlobalData on MSN2d
FDA approves drug application for Lupin’s heart failure therapyThe US Food and Drug Administration (FDA) has approved the abbreviated new drug application (ANDA) of Lupin’s Sacubitril and ...
Lupin receives US FDA marketing nod for generic Triumeq PD tablets for oral suspension to trteat HIV-1 infection: Our Bureau, Mumbai Friday, January 24, 2025, 14:15 Hrs [IST] Glob ...
Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug ...
Lupin’s Nagpur facility receives EIR from US FDA The Establishment Inspection Report (EIR) was issued post the last inspection of the facility conducted from October 17, 2022 to October 29 ...
Lupin has received tentative approval from the USFDA to market a generic HIV drug in the US under PEPFAR. The drug, made at ...
thereby significantly boosting our HIV medication portfolio," Lupin Executive Director, Global CFO & Head of API Plus SBU Ramesh Swaminathan said. Shares of Lupin were trading 0.78 per cent down at Rs ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback